Search Results - Kunal Saxena

Cost-effectiveness of nonavalent HPV vaccination in the Netherlands by Cody Palmer, Christiaan Dolk, Ugne Sabale, Wei Wang, Kunal Saxena

Connect to this object online.

Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India by John R. Cook, Kunal Saxena, Catharine Taylor, Jeffrey L. Jacobs

Connect to this object online.

HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US by Kunal Saxena, Niranjan Kathe, Poorva Sardana, Lixia Yao, Ya-Ting Chen, Noel T. Brewer

Connect to this object online.

Assessing the long-term implications of age 9 initiation of HPV vaccination on series completion by age 13-15 in the US: projections from an age-structured vaccination model by Kunal Saxena, Oscar Patterson-Lomba, Andres Gomez-Lievano, Abigail Zion, Jennifer Cunningham-Erves, Deanna Kepka

Connect to this object online.

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong by Tak Hong Cheung, Sally Shuk Yee Cheng, Danny Hsu, Queenie Wing-Lei Wong, Andrew Pavelyev, Isaya Sukarom, Kunal Saxena

Connect to this object online.

Changes in vaccine administration trends across the life-course during the COVID-19 pandemic in the United States: a claims database study by Amanda L. Eiden, Anthony DiFranzo, Alexandra Bhatti, H. Echo Wang, Goran Bencina, Lixia Yao, Kunal Saxena, Ya-Ting Chen, Stephanie A. Kujawski

Connect to this object online.